Answers are grounded in this paper and cite their sources.
Our institution is expanding the application of TLM to selected patients with T3 laryngeal carcinoma. Oncological outcomes have not been jeopardized by this approach and the treatment is well tolerated by patients with few complications.
No takes yet. Share an insight, caveat, or question.
Butler et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: